BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1981493)

  • 1. Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
    Holmes D; Fryda-Kaurimsky Z; Krueger K
    Cardiology; 1990; 77(6):459-65. PubMed ID: 1981493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem.
    Meyer EC; Makov UE; Palant A
    Cardiology; 1991; 78(3):179-84. PubMed ID: 1678316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
    Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
    Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bopindolol and atenolol in chronic stable angina pectoris.
    Fitscha P; Meisner W; Tiso B
    Eur J Clin Pharmacol; 1990; 38(1):81-4. PubMed ID: 1970300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
    Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 9. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
    J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind study of pindolol in patients with stable angina pectoris.
    Harston WE; Friesinger GC
    Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
    Harston WE; Friesinger GC
    Am J Cardiol; 1982 Oct; 50(4):722-7. PubMed ID: 6127028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term antihypertensive effect of bopindolol once daily or once weekly.
    Andersson O; Hedner T; Nyberg G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S74-6. PubMed ID: 2439826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effect of the beta blocker timolol in stable agina pectoris.
    Di Segni E; Fidelman E; David D; Klein HO; Kaplinsky E
    Angiology; 1980 Apr; 31(4):238-45. PubMed ID: 6103680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E; Wagner G; vd Ven LL; Lie KI
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous and oral pindolol on exercise tolerance and electrocardiographic changes in angina pectoris.
    Storstein L
    J Cardiovasc Pharmacol; 1980; 2(6):739-50. PubMed ID: 6160324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-finding study with bopindolol in arterial hypertension.
    Willimann P; Peter R; Siegenthaler H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
    Bonelli J; Gazo F; Falkner C; Liedtke RK
    Arzneimittelforschung; 1990 Aug; 40(8):876-9. PubMed ID: 1978680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.